OpenLB
Open Library of Bioscience
Advanced Search
British journal of pharmacology
02, 2020;177 (3): 467-468.

Challenges in the development and exploitation of new therapeutic options targeting the histaminergic system.

Paul L Chazot, Ekaterini Tiligada
Author Information
  1. Paul L Chazot: Department of Biosciences, Durham University, Durham, UK.
  2. Ekaterini Tiligada: Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
PMID: 31994717 DOI: 10.1111/bph.14947

Abstract

LINKED ARTICLES: This article is part of a themed section on New Uses for 21st Century Antihistamines. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.3/issuetoc.

References

  1. Br J Pharmacol. 2020 Feb;177(3):600-613 [PMID: 31328788]
  2. Br J Pharmacol. 2020 Feb;177(3):469-489 [PMID: 30341770]
  3. Br J Pharmacol. 2020 Feb;177(3):503-515 [PMID: 30741418]
  4. Br J Pharmacol. 2020 Feb;177(3):490-502 [PMID: 30460986]
  5. Br J Pharmacol. 2020 Feb;177(3):539-556 [PMID: 30129226]
  6. Br J Pharmacol. 2020 Feb;177(3):580-599 [PMID: 31046146]
  7. Br J Pharmacol. 2020 Feb;177(3):570-579 [PMID: 30714121]
  8. Br J Pharmacol. 2020 Feb;177(3):623-633 [PMID: 31347148]
  9. Br J Pharmacol. 2020 Feb;177(3):516-538 [PMID: 30414378]
  10. Br J Pharmacol. 2020 Feb;177(3):634-641 [PMID: 30801695]
  11. Br J Pharmacol. 2020 Feb;177(3):614-622 [PMID: 30589077]
  12. Br J Pharmacol. 2020 Feb;177(3):557-569 [PMID: 30110713]
Editorial
Article has an altmetric score of 1

Word Cloud

Created with Highcharts 10.0.0sectionLINKEDARTICLES:articlepartthemedNewUses21stCenturyAntihistaminesviewarticlesvisithttp://onlinelibrarywileycom/doi/101111/bphv1773/issuetocChallengesdevelopmentexploitationnewtherapeuticoptionstargetinghistaminergicsystem

Similar Articles

Cited By

No available data.